| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Fixed maturities, available for sale, at fair value (net of allowance for credit losses september30, 2025 - 33.0 and december31, 2024 - 37.1 amortized cost september30, 2025 - 25,219.3 and december31, 2024 - 25,151.0) | 23,405,300 | 23,047,000 | ||
| Equity securities at fair value | 377,200 | 387,400 | ||
| Mortgage loans (net of allowance for credit losses september30, 2025 - 21.0 and december31, 2024 - 13.6) | 3,042,700 | 2,834,300 | ||
| Policy loans | 141,200 | 137,600 | ||
| Trading securities | 296,900 | 308,300 | ||
| Investments held by variable interest entities (net of allowance for credit losses september30, 2025 - 0.5 and december31, 2024 - 1.3 amortized cost september30, 2025 - 298.6 and december31, 2024 - 437.0) | 296,800 | 376,900 | ||
| Other invested assets | 1,617,000 | 1,500,500 | ||
| Total investments | 29,177,100 | 28,592,000 | ||
| Cash and cash equivalents - unrestricted | 1,218,300 | 766,000 | ||
| Cash and cash equivalents held by variable interest entities | 23,300 | 50,000 | ||
| Accrued investment income | 282,000 | 279,400 | ||
| Present value of future profits | 147,800 | 152,100 | ||
| Deferred acquisition costs | 2,343,700 | 2,276,300 | ||
| Reinsurance receivables (net of allowance for credit losses september30, 2025 - 1.0 and december31, 2024 - 3.0) | 3,731,700 | 3,753,900 | ||
| Income tax assets, net | 708,100 | 749,300 | ||
| Assets held in separate accounts | 2,700 | 2,900 | ||
| Other assets | 661,500 | 707,200 | ||
| Total assets | 38,296,200 | 37,329,100 | ||
| Policyholder account values, end of period excluding contracts 100 ceded | 17,872,300 | - | ||
| Policyholder account values, end of period for contracts 100 ceded | 752,400 | - | ||
| Amount of reserves above (below) policyholder account values | -334,400 | - | ||
| Policyholder account balances | 18,290,300 | 17,609,000 | ||
| Future policy benefits | 11,975,500 | 11,787,700 | ||
| Market risk benefit liability | 52,600 | 63,800 | ||
| Liability for life insurance policy claims | 61,500 | 60,700 | ||
| Unearned and advanced premiums | 214,500 | 217,300 | ||
| Liabilities related to separate accounts | 2,700 | 2,900 | ||
| Other liabilities | 1,036,900 | 935,800 | ||
| Investment borrowings | 2,441,700 | 2,441,700 | ||
| Borrowings related to variable interest entities | 274,300 | 352,800 | ||
| Notes payable direct corporate obligations | 1,335,200 | 1,334,700 | ||
| Total liabilities | 35,685,200 | 34,806,400 | ||
| Common stock (0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding september30, 2025 95,840,989 december31, 2024 101,618,957) | 1,000 | 1,000 | ||
| Additional paid-in capital | 1,389,400 | 1,441,400 | ||
| Accumulated other comprehensive loss | -1,118,900 | -1,252,700 | ||
| Retained earnings | 2,339,500 | 2,333,000 | ||
| Total shareholders' equity | 2,611,000 | 2,522,700 | ||
| Total liabilities and shareholders' equity | 38,296,200 | 37,329,100 | ||
CNO Financial Group, Inc. (CNO)
CNO Financial Group, Inc. (CNO)